Effect of Lactobacillus supplementation with and without arginine on liver damage and bacterial translocation in an acute liver injury model in the rat

Hepatology

Volumn 25, Issue 3, 1997, Pages 642-647

  Adawi, Diya ^a   Behzad Kasravi, F ^a   Molin, Göran ^a   Jeppsson, Bengt ^a,b  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; BILIRUBIN; GALACTOSAMINE; LIVER ENZYME;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL TRANSLOCATION; CONTROLLED STUDY; ENTEROBACTERIACEAE; INFLAMMATORY INFILTRATE; INTESTINE FLORA; LACTOBACILLUS; LIVER INJURY; LIVER NECROSIS; LIVER PROTECTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECTAL DRUG ADMINISTRATION;

ALANINE TRANSAMINASE; ANIMALS; ARGININE; ASPARTATE AMINOTRANSFERASES; BACTERIAL TRANSLOCATION; BIOLOGY; CECUM; COLON; COLONY COUNT, MICROBIAL; GALACTOSAMINE; LACTOBACILLUS; LIVER FAILURE; LYMPH NODES; MALE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 20644468617     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510250325     Document Type: Article

References (17)

1. Fernandes CF, Shahani KM, Amer MA. Therapeutic role of dietary lactobacilli and lactobacillic fermented dairy products. FEMS Microbiol Rev 1987;46:343-356.
2. Axelsson L. Lactobacillus reuteri, a member of the gut bacterial flora. Uppsala, Sweden: Swedish University of Agricultural Science, Department of Microbiology; 1990. Thesis.
3. Suva M, Jacobus NV, Deneke C, Gorbach SL. Antimicrobial substance from human Lactobacillus strain. Antimicrob Agents Chemother 1987;31: 1231-1233.
4. Axelsson LT, Chung TC, Dobrogsz WJ, Lindgren SE. Production of broad spectrum antimicrobial substance by Lactobacillus reuteri. Micr Ecol Health Dis 1989;2:131-136.
5. Gilliland SE, Speck ML. Antagonistic action of Lactobacillus acidophilus toward intestinal and food-born pathogens in associative cultures. Journal of Food Protection 1977;40:820-823.
6. Fuller R. Probiotics in human medicine. Gut 1991;32:439-442.
7. Sato K, Saito H, Tomioka H. Enhancement of host resistance against Listeria infection by Lactobacillus casei: activation of liver macrophages and peritoneal macrophages by Lactobacillus casei. Microbiol Immunol 1988;32:689-698.
8. Kato I, Kobayashi S, Yokokura T, Mutai M. Antitumor activity of Lactobacillus casei in mice. Gann 1981;72:517-523.
9. Perdigon G, De Macias MEN, Alvares S, Oliver G, De Ruizholgado AP. Effect of perorally administered lactobacilli on macrophage activation in mice. Infect Immun 1986;53:404-410.
10. Perdigon G, Alvarez S, De Macias ME, Roux ME, De Ruizholgado AP. The oral administration of lactic acid bacteria increases the mucosal intestinal immunity in response to enteropathogens. Journal of Food Protection 1990;53:404-410.
11. Gorbach SL, Chang TW, Goldin B. Successful treatment of relapsing Clostridium difficile colitis with Lactobacillus GG. Lancet 1987;2:1519.
12. Colombell JF, Cortot A, Neut C, Romond C. Yoghurt with Bifidobacterium longum reduces erythromycin-induced gastrointestinal effects. Lancet 1987;2:43.
13. Tvede M, Rask-Madsen J. Bacteriotherapy for chronic relapsing Clostridium difficile diarrhoea in six patients. Lancet 1989;1:1156-1160.
14. Tyszkiewicz T, Tvede M, Malina M, Ljungberg O, Roos H. Bacteriotherapy for distal colitis [Abstract]. Gastroenterology 1991;100 (suppl 5):259A.
15. Borody TJ, George L, Andrews P, Brandi S, Noonan S, Cole P, Hyland L, et al. Bowel-flora alteration: a potential cure for inflammatory bowel disease and irritable bowel syndrome? Med J Aust 1989;150:604.
16. Barbul A. Arginine: biochemistry, physiology and therapeutic implications. JPEN 1986;10:227-238.
17. Barbul A, Sisto DA, Wasserkrug HL, Efron G. Arginine stimulates lymphocyte immune responses in healthy human beings. Surgery 1981;90:244-251.